The Best GLP-1 Drug on the Market Is Even Better Than We Knew - Gizmodo
The Best GLP-1 Drug on the Market Is Even Better Than We Knew Gizmodo Tirzepatide significantly reduces cardiovascular risk in high-risk patients News-Medical Popular weight loss drug linked to key benefits for patients undergoing TAVR, PCI Cardiovascular Business Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Nature Q&A: Tirzepatide Outperforms Dulaglutide in Cardiorenal Outcomes, With Steven Nissen, MD Patient Care Online source https://news.google.com/rss/articles/CBMilwFBVV95cUxNVmpYb1lWTXR3WXJ4WEk1YUtxVmZhWml1eURXMnhGV0R1WEJVSmlOVHJlNHJDTjNmUmlmekZHX2FRaTdnSmQycEFTRU5VcUN3aXpUVWZickFBUEo1X194U2RNY0F2Mi10ZE8yVDhtRGRtX05vZTB1SEU0RkdjQXBmbFVidnZyTnpUMG9hU09FdGItM05oTWJF?oc=5